CTOs on the Move


 
bioVIGIL headquartered in Las Vegas, Nevada, is a leading provider of healthcare infection control and disease mitigation solutions that enhance the patient care environment improving patient safety, healthcare quality, and hospital bottom lines.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

New West Health Services

At New West, we believe it makes more sense to help you stay healthy rather than just caring for you after you've become sick or injured. That's why we've developed a full line of products to give you the best choice in group and individual health care

ElTovier

ElTovier is a Norwalk, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sun Bridge Healthcare

Sun Bridge Healthcare is a Northampton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mohawk Valley Health System

Mohawk Valley Health System is an integrated healthcare delivery system which includes St. Elizabeth Medical Center and Faxton St. Luke`s Healthcare, serving Oneida, Herkimer and Madison counties. We offer inpatient, primary, multi-specialty and long-term care. Services also include bariatric surgery, maternal child services, stroke care, surgical services, orthopedic services, cancer care, dialysis, diabetes program, rehabilitation, home care, cardiac care, imaging, wound care, emergency services, urgent care, outpatient laboratory services and more.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.